
Find Reports
Select Report Type
Reimbursement Review
Displaying 851 - 875 of 1422
Please scroll or swipe to the right to view the full content.
Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
---|---|---|---|---|---|---|---|---|---|
Ticagrelor | Brilinta | Ticagrelor | Acute coronary syndromes | Do not list | Complete | SR0234-000 | |||
Fentanyl Citrate | Abstral | Fentanyl citrate | Pain, breakthrough cancer pain | Do not list | Complete | SR0240-000 | |||
Telmisartan/ Amlodipine | Twynsta | Telmisartan/ Amlodipine | Hypertension | List | Complete | SR0245-000 | |||
Fingolimod | Gilenya | Fingolimod | Multiple Sclerosis, relapsing-remitting | List with clinical criteria and/or conditions | Complete | SR0228-000 | |||
Denosumab | XGEVA | Denosumab | Prevention of skeletal-related events due to bone metastases from solid tumours | List with clinical criteria and/or conditions | Complete | SR0235-000 | |||
Zoledronic acid | Aclasta | Zoledronic acid | Osteoporosis | List with clinical criteria and/or conditions | Complete | SF0242-000 | |||
Boceprevir | Victrelis | Boceprevir | Hepatitis C, chronic | List with clinical criteria and/or conditions | Complete | SR0231-000 | |||
Eltrombopag olamine | Revolade | Eltrombopag olamine | Chronic immune thrombocytopenic purpura | Do not list | Complete | SR0230-000 | |||
Alitretinoin | Toctino | Alitretinoin | Eczema | List with clinical criteria and/or conditions | Complete | SR0232-000 | |||
Liraglutide | Victoza | Liraglutide | Diabetes mellitus, Type 2 | Do not list | Complete | SR0217-000 | |||
Tapentadol | Nucynta CR | Tapentadol | Pain, moderate to moderately severe | Do not list | Complete | SR0224-000 | |||
Mometasone furoate and formote... | Zenhale (inhalation aerosol) | Mometasone furoate and formoterol | Asthma | Do not list | Complete | SR0225-000 | |||
Buprenorphine transdermal patc... | BuTrans | Buprenorphine transdermal patch | Pain, moderate intensity persistent pain | Do not list | Complete | SR0233-000 | |||
Roflumilast | Daxas | Roflumilast | Chronic obstructive pulmonary disease | Do not list | Complete | SR0218-000 | |||
Aztreonam for inhalation solut... | Cayston | Aztreonam for inhalation solution | Cystic fibrosis, chronic pulmonary pseudomonas aeruginosa infections | List with clinical criteria and/or conditions | Complete | SR0220-000 | |||
Cyclosporine | Restasis ophthalmic emulsion | Cyclosporine | Dry eye disease | Do not list | Complete | SR0222-000 | |||
Maraviroc | Celsentri | Maraviroc | HIV infection | Do not list | Complete | SR0221-000 | |||
Aripiprazole | Abilify | Aripiprazole | Schizophrenia and related psychotic disorders | List with clinical criteria and/or conditions | Complete | SF0226-000 | |||
Dabigatran etexilate | Pradaxa | Dabigatran etexilate | Atrial fibrillation prevention of stroke and systemic embolism | List with clinical criteria and/or conditions | Complete | SR0214-000 | |||
Paliperidone palmitate | Invega Sustenna | Paliperidone palmitate | Schizophrenia | Do not list | Complete | SR0206-000 | |||
Febuxostat | Uloric | Febuxostat | Gout | List with clinical criteria and/or conditions | Complete | SR0213-000 | |||
Lacosamide | Vimpat | Lacosamide | Epilepsy, partial onset seizures | List with clinical criteria and/or conditions | Complete | SR0212-000 | |||
Velaglucerase alfa | VPRIV | Velaglucerase alfa | Gaucher Disease | List with clinical criteria and/or conditions | Complete | SR0215-000 | |||
Denosumab | Prolia | Denosumab | Osteoporosis, postmenopausal women | List with clinical criteria and/or conditions | Complete | SR0208-000 | |||
Prasugrel hydrochloride | Effient | Prasugrel hydrochloride | Acute Coronary Syndrome | Do not list | Complete | SR0200-000 |
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 851 - 875 of 2132
Please scroll or swipe to the right to view the full content.
Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
---|---|---|---|---|---|---|---|
CADTH and the Canadian Institute for Health Information (CIHI) Real-World Evidence Feasibility Collaboration | Health Technology Review | Technology Review | Completed | CP0027 - HC0019 | |||
Aprepitant for the Prevention of Post-Operative Nausea and Vomiting in Refractory or High-Risk Patients | Health Technology Review | Rapid Review | Completed | RC1430-000 | |||
bimekizumab | Reimbursement Review | Complete | SR0698-000 | ||||
Stepped Care Models for Chronic Pain | Health Technology Review | Technology Review | Completed | HC0034-000 | |||
Reconsolidation and Consolidation Therapies for the Treatment and Prevention of Post-Traumatic Stress Disorder | Health Technology Review | Rapid Review | Completed | RC1424-000 | |||
Multiple myeloma | Reimbursement Review | Provisional Funding Algorithm | Complete | PH0011-000 | |||
An Overview of Continuous Learning Artificial Intelligence-Enabled Medical Devices | Horizon Scan | Emerging Health Technologies | Completed | EH0102-000 | |||
Robotic-Assisted Spinal Surgery | Health Technology Review | Rapid Review | RC1427-000 | ||||
Melatonin for the Treatment of Insomnia: A 2022 Update | Health Technology Review | Rapid Review | Completed | RC1422-000 | |||
Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer | Reimbursement Review | Provisional Funding Algorithm | Complete | PH0009-000 | |||
Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Detachment Surgery | Health Technology Review | Rapid Review | RC1428-000 | ||||
Pre-Surgical Screening Tools and Risk Factors for Chronic Post-Surgical Pain | Health Technology Review | Technology Review | Completed | HC0023-000 | |||
dinutuximab | Reimbursement Review | Complete | PC0222-000 | ||||
Melatonin for the Treatment or Prevention of Delirium | Health Technology Review | Rapid Review | Completed | RC1421-000 | |||
An Overview of New and Emerging Technologies for Early Diagnosis of Alzheimer Disease | Horizon Scan | Emerging Health Technologies | Completed | EH0103-000 | |||
Clinical Effectiveness of Second Generation Injectable Antipsychotics | Health Technology Review | Rapid Review | Completed | RC1418-000 | |||
somatrogon | Reimbursement Review | Complete | SR0683-000 | ||||
Cost-Effectiveness of Treatment for Pediatric Immune Thrombocytopenia | Health Technology Review | Rapid Review | Completed | RC1425-000 | |||
fedratinib | Reimbursement Review | Complete | PC0205-000 | ||||
Management of HIV in Primary Care Settings | Health Technology Review | Technology Review | Completed | HC0028-000 | |||
isatuximab | Reimbursement Review | Complete | PC0256-000 | ||||
Hub-and-Spoke Models of Care for Chronic Pain | Health Technology Review | Technology Review | Completed | HC0030-000 | |||
pertuzumab | Reimbursement Review | Complete | PC0241-000 | ||||
Pharmacological Therapies for COVID-19 | Health Technology Review | Technology Review | |||||
Tirzepatide for Type 2 diabetes mellitus | Horizon Scan | Emerging Health Technologies | Completed | EH0104-000 |